import serviceImage from '@/assets/containment-validation/surrogate-testing.jpg';
const link = '/services/containment-validation/surrogate-testing';

export default {
  slug: 'surrogate-testing',
  parentSlug: 'containment-validation',
  service_id: 'CV-ST-010',
  report_type: 'Comprehensive Surrogate Containment Performance Report',
  title: 'Pharmaceutical Surrogate Powder Testing | Containment Validation | Indivirtus',
  name: 'Advanced Surrogate Containment Testing',
  description:
    'Quantitative evaluation of pharmaceutical containment systems using engineered surrogate materials and advanced detection methods.',
  full_description:
    'Our Surrogate Powder Testing service provides scientifically rigorous validation of containment systems for potent compound handling. We employ a multi-modal approach using: fluorescent tracers (sodium fluorescein) for visual breach detection, engineered lactose/naproxen blends matching target API particle characteristics, and specialized surrogate APIs for biologics. Our testing includes real-time airborne particle monitoring with simultaneous video recording, 3D contamination mapping using UV-visible tracers, and quantitative analysis via HPLC with detection limits to ng/cm². For cytotoxic applications, we offer ultra-sensitive LC-MS/MS analysis. All studies are designed per ISPE SMEPAC guidelines and include worst-case scenario simulations (equipment failures, improper PPE use) to stress-test containment strategies. Results are benchmarked against OELs and presented with actionable engineering controls to achieve ALARP (As Low As Reasonably Practicable) conditions.',
  estimated_duration: '7–14 days (includes protocol development, execution, and comprehensive reporting)',
  deliverables: [
    'Risk-based test protocol with acceptance criteria',
    'High-resolution contamination heat maps',
    'Time-synchronized video/particle data',
    'Quantitative containment performance metrics',
    'Comparative analysis against OEB requirements',
    'Engineering control improvement roadmap',
    'Regulatory-ready documentation package',
  ],
  regulatory_basis: [
    'ISPE SMEPAC Guidelines (2021)',
    'EU GMP Annex 1 (2022) - Contamination Control Strategy',
    'OSHA 29 CFR 1910.1000 (Air Contaminants)',
    'NIOSH Hazardous Drug Handling Guidelines',
    'EMA Guideline on Setting Health Based Exposure Limits',
    'ISO 14644-7 (Cleanroom Isolators)',
  ],
  requires_data_from_client: true,
  target_industry: ['Pharmaceutical', 'Biotech', 'CDMO', 'Sterile Manufacturing', 'HPAPI', 'Oncology Drug Production'],
  expertise_area: [
    'Containment Engineering',
    'Exposure Science',
    'Risk-Based Validation',
    'Occupational Hygiene',
    'Regulatory Compliance',
  ],
  is_active: true,
  pageLink: link,
  icon: '🌫️',
  image: {
    path: serviceImage,
    alt: 'Pharmaceutical containment validation using fluorescent surrogate powders',
    caption: 'Engineer conducting surrogate powder testing with real-time particle monitoring in isolator',
  },
  gtm: {
    eventCategory: 'Containment Validation Services',
    eventAction: 'Surrogate Testing Inquiry',
    eventLabel: 'Containment Performance Evaluation',
    customDimensions: {
      compoundClass: 'Small Molecule/Biologic',
      containmentLevel: 'Primary/Secondary',
    },
    dataLayerPush: {
      reportType: ['Surrogate Testing', 'Containment Validation'],
      certification: ['SMEPAC', 'GMP Compliant'],
    },
  },
  schema: {
    '@context': 'https://schema.org',
    '@type': 'ProfessionalService',
    name: 'Pharmaceutical Surrogate Containment Testing',
    description:
      'Advanced surrogate powder testing services for validation of pharmaceutical containment systems using engineered materials and quantitative exposure assessment methods.',
    serviceType: 'Pharmaceutical Validation Service',
    provider: {
      '@type': 'Organization',
      name: 'Indivirtus Healthcare Solutions',
      url: 'https://www.indivirtus.com',
      logo: 'https://www.indivirtus.com/logo.png',
      sameAs: [
        'https://www.linkedin.com/company/indivirtus-group-of-companies',
        'https://twitter.com/indivirtus',
        'https://www.facebook.com/Indivirtus',
        'https://www.instagram.com/indivirtus_healthcare',
      ],
    },
    areaServed: {
      '@type': 'Country',
      name: 'Global',
    },
    availableChannel: {
      '@type': 'ServiceChannel',
      serviceUrl: link,
      servicePhone: '+91-9131925456',
      servicePostalAddress: {
        '@type': 'PostalAddress',
        streetAddress: '522, Taj Plaza, TDI city, Sector 118',
        addressLocality: 'Mohali',
        addressRegion: 'Punjab',
        postalCode: '160059',
        addressCountry: 'India',
      },
    },
    hasOfferCatalog: {
      '@type': 'OfferCatalog',
      name: 'Surrogate Testing Services',
      itemListElement: [
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Engineered Surrogate Testing',
            description:
              'Custom-formulated surrogate powders matching target API particle characteristics (size, shape, charge) for realistic simulation.',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Fluorescent Tracer Studies',
            description:
              'High-sensitivity contamination mapping using UV-visible tracers with quantitative image analysis.',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Worst-Case Scenario Testing',
            description:
              'Deliberate stress testing of containment systems during simulated failures and improper handling.',
          },
        },
        {
          '@type': 'Offer',
          itemOffered: {
            '@type': 'Service',
            name: 'Cytotoxic Surrogate Analysis',
            description:
              'Ultra-sensitive LC-MS/MS detection for surrogate testing at cytotoxic compound requirements (pg/cm²).',
          },
        },
      ],
    },
    offers: {
      '@type': 'Offer',
      priceCurrency: ['INR', 'USD', 'EUR'],
      price: 'Risk-based tiered pricing',
      url: link,
      availability: 'https://schema.org/InStock',
      businessFunction: 'https://schema.org/ProvideService',
    },
  },
  faqSchema: {
    '@context': 'https://schema.org',
    '@type': 'FAQPage',
    mainEntity: [
      {
        '@type': 'Question',
        name: 'How do you select appropriate surrogate materials for specific APIs?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'We match surrogates to APIs based on: 1) Particle size distribution (laser diffraction analysis), 2) Morphology (SEM imaging), 3) Electrostatic properties, and 4) Flow characteristics - using engineered lactose blends or custom particles when needed to simulate challenging APIs.',
        },
      },
      {
        '@type': 'Question',
        name: 'Can surrogate testing validate containment for nanogram-potent compounds?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Yes, we use: 1) Fluorescent tracers detectable at <1ng/cm², 2) LC-MS/MS analysis for specific surrogate compounds, and 3) Statistical extrapolation models to verify containment at required levels for ultra-potent compounds.',
        },
      },
      {
        '@type': 'Question',
        name: 'How does Annex 1 (2022) impact surrogate testing approaches?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'The updated Annex 1 requires: 1) Integration with Contamination Control Strategy, 2) More frequent performance verification, and 3) Linkage to media fill simulations for aseptic processes. Our testing protocols now include these elements with documented correlations.',
        },
      },
      {
        '@type': 'Question',
        name: "What's the advantage of time-synchronized video/particle data?",
        acceptedAnswer: {
          '@type': 'Answer',
          text: 'Synchronization allows: 1) Precise identification of contaminant-generating activities, 2) Correlation of particle counts with specific operations, and 3) Visual evidence for training and procedure optimization - creating a powerful diagnostic tool.',
        },
      },
      {
        '@type': 'Question',
        name: 'Can you test containment for large-scale manufacturing equipment?',
        acceptedAnswer: {
          '@type': 'Answer',
          text: "Absolutely. We've developed scalable methods for: 1) Bin blenders and fluid bed dryers, 2) Continuous manufacturing lines, and 3) Large-scale isolators - using distributed sampling arrays and computational fluid dynamics modeling to extrapolate results.",
        },
      },
    ],
  },
  meta: {
    title: 'Pharmaceutical Surrogate Testing Services | Containment Validation | Indivirtus',
    description:
      'Comprehensive surrogate powder testing for pharmaceutical containment validation - engineered materials, fluorescent tracers, and quantitative analysis to verify OEB compliance.',
    keywords: [
      'pharmaceutical surrogate testing',
      'containment performance validation',
      'fluorescent tracer studies',
      'OEB compliance testing',
      'cytotoxic containment verification',
      'SMEPAC testing service',
      'powder handling simulation',
      'ALARP verification',
    ],
    ogTags: {
      type: 'service',
      image: serviceImage.src,
      url: link,
      site_name: 'Indivirtus Healthcare Solutions',
    },
    twitterCard: {
      card: 'summary_large_image',
      title: 'Pharma Surrogate Testing | Containment Validation Experts',
      description:
        'Advanced surrogate powder testing services for validation of pharmaceutical containment systems using engineered materials and quantitative methods.',
      image: serviceImage.src,
    },
    canonicalUrl: `https://www.indivirtus.com${link}`,
    robotsMeta: {
      index: true,
      follow: true,
      nocache: false,
      googleBot: 'index, follow, max-image-preview:large',
    },
  },
  assessmentTypes: [
    'Engineered Surrogate Testing',
    'Fluorescent Tracer Mapping',
    'Containment Performance Rating',
    'Worst-Case Scenario Validation',
    'OEB Compliance Verification',
    'ALARP Achievement Assessment',
  ],
};
